Impact of natremia on metastatic non small cell lung cancer patients receiving immune checkpoint inhibitors.

Autor: Catalano M; Department of Health Science, University of Florence, Florence, 50134, Italy., Fancelli S; Clinical Oncology Unit, Careggi University Hospital, Florence, 50234, Italy., Caliman E; Clinical Oncology Unit, Careggi University Hospital, Florence, 50234, Italy., Mazzoni F; Clinical Oncology Unit, Careggi University Hospital, Florence, 50234, Italy., Michelet MG; Department of Experimental and Clinical Medicine, University of Florence, Florence, 50134, Italy., Mancini S; Department of Experimental and Clinical Medicine, University of Florence, Florence, 50134, Italy., Manneschi C; Department of Experimental and Clinical Medicine, University of Florence, Florence, 50134, Italy., Shabani S; Department of Experimental and Clinical Medicine, University of Florence, Florence, 50134, Italy., Napolitano B; Department of Experimental and Clinical Medicine, University of Florence, Florence, 50134, Italy., Pillozzi S; Department of Experimental and Clinical Biomedical Sciences 'Mario Serio', University of Florence, Florence, 50134, Italy., Antonuzzo L; Clinical Oncology Unit, Careggi University Hospital, Florence, 50234, Italy.; Department of Experimental and Clinical Medicine, University of Florence, Florence, 50134, Italy., Roviello G; Department of Health Science, University of Florence, Florence, 50134, Italy. giandomenico.roviello@unifi.it.

Publikováno v: Scientific reports [Sci Rep] 2024 Nov 29; Vol. 14 (1), pp. 29655. Date of Electronic Publication: 2024 Nov 29.